Breast Cancer Drugs Battle Disease’s Return

Xeloda lowered risk by a third, while Xgeva lowered chances by 18 percent, researchers report

Source: The Doctors Lounge - Oncology - December 9, 2015 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Gynecology, Oncology, Pharmacy, Research, News, Source Type: news